IRONWOOD PHARMACEUTICALS, INC. (IRWD) Net margin 2016–2025
IRONWOOD PHARMACEUTICALS, INC. (IRWD) net profit margin by fiscal year — reported net income divided by reported revenue.
8.1%FY2025 · since FY2016: -29.8% → 8.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 8.1% | +7.9 pp |
| FY2024 | 0.3% | +226.6 pp |
| FY2023 | -226.4% | -269.0 pp |
| FY2022 | 42.6% | -85.1 pp |
| FY2021 | 127.7% | +100.5 pp |
| FY2020 | 27.3% | +22.2 pp |
| FY2019 | 5.0% | +86.5 pp |
| FY2018 | -81.5% | -42.3 pp |
| FY2017 | -39.2% | -9.4 pp |
| FY2016 | -29.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More IRWD financial trends
IRWD RevenueIRWD Net incomeIRWD Gross profitIRWD Gross marginIRWD Operating incomeIRWD Operating marginIRWD Operating cash flowIRWD Free cash flowIRWD Capital expendituresIRWD Return on equityIRWD Stock buybacksIRWD Dividends paidIRWD Total assetsIRWD Total liabilitiesIRWD Shareholders’ equityIRWD overview →